BIOCARDIA INC (BCDA:NASDAQ)
$0.881 0.0859 (10.8037%)
Analysed BIOCARDIA INC (BCDA:NASDAQ) News Sources
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
19-05-2026
yahoo.com
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
21-05-2026
yahoo.com
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure
28-05-2026
yahoo.com
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF
05-06-2026
yahoo.com
BioCardia Shares Rally After FDA Supports Regulatory Path for Heart Failure Therapy (BCDA)
05-06-2026
advfn.com
Why Did BCDA Stock Surge More Than 50% Today?
05-06-2026
stocktwits.com
Top Midday Gainers
05-06-2026
yahoo.com
Sector Update: Healthcare Stocks Gain Friday Afternoon
05-06-2026
yahoo.com
Sector Update: Healthcare Stocks Higher Late Afternoon
05-06-2026
yahoo.com
BioCardia Announces $4.4 Million Financing
08-06-2026
yahoo.com
What is the current price of BIOCARDIA INC (BCDA:NASDAQ)?
The current price of BIOCARDIA INC (BCDA:NASDAQ) is $0.881.
BIOCARDIA INC (BCDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCARDIA INC (BCDA:NASDAQ) since the previous trading day is $0.0859.
BIOCARDIA INC (BCDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCARDIA INC (BCDA:NASDAQ) since the previous trading day is 10.8037%.
What is the most recent average sentiment score for BIOCARDIA INC (BCDA:NASDAQ)?
The most recent average sentiment score for BIOCARDIA INC (BCDA:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for BIOCARDIA INC (BCDA:NASDAQ)?
The most recent sentiment for BIOCARDIA INC (BCDA:NASDAQ) is .
SEC-8K** Filing Available For BIOCARDIA INC (BCDA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.